ライフサイエンスコーパス: lethargy

1 or a frontal headache, eye pain, emesis, and lethargy.

2 ntries, may relieve vertigo symptoms without lethargy.

3 of food ingestion with repetitive emesis and lethargy.

4 tis, like hyperactivity, circling, seizures, lethargy.

5 urrent visual hallucinations and progressive lethargy.

6 maphrodite and the recovery from post-coital lethargy.

7 s, ocular and nasal discharge, sneezing, and lethargy.

8 signaling in mediating inflammation-induced lethargy.

9 ing opiates, that induce sedation and mental lethargy.

10 regurgitation, inappetance, weight loss, and lethargy.

11 ion, in both instances, was with malaise and lethargy.

12 terminal work to eye symptoms, headache, and lethargy.

13 resistance, impaired glucose tolerance, and lethargy.

14 Nine patients had lethargy, 1 had ataxia, and 1 had respiratory insufficie

15 33%]), diarrhoea (14 [18%] vs 23 [25%]), and lethargy (20 [26%] vs 19 [21%]).

16 and vomiting (30%), irritability (24%), and lethargy (21%) for children aged under 4 years with intr

17 a (50%), vomiting (34%), and fatigue/malaise/lethargy (24%).

18 p vs 65 [28%] of 231 in the ablation group), lethargy (34 [14%] vs 32 [14%]), and dry mouth (24 [10%]

19 ved radiotherapy for a PTM) and tiredness or lethargy (36 [39%] in the immediate radiotherapy group v

20 kles (89% vs 76%), hypoxia (50% vs 36%), and lethargy (36% vs 20%).

21 res preceding the rash included fever (62%), lethargy (41%), myalgia (31%), and headache (27%); lymph

22 patients), skin toxicity (41 [19%] vs none), lethargy (45 [21]% vs 24 [11%]), infection (42 [19%] vs

23 vs 797 events), leucopenia (507 vs 362), and lethargy (456 vs 272).

24 signs were respiratory changes (68.73%) and lethargy (47.79%).

25 composite of asthenia, fatigue, malaise, or lethargy (56% with any grade, 9% with grade 3).

26 Repetitive vomiting (100%), lethargy (86%), and pallor (61%) were common symptoms; 4

27 by persistent fever that is associated with lethargy, abdominal pain, vomiting and/or diarrhea, and,

28 P) study found factors, including drowsiness/lethargy, age, ataxia, abdominal pain, and electrolyte a

29 de effect (gastrointestinal event, headache, lethargy, alopecia, cough, or dyspnea).

30 sistent with the known sickness behaviors of lethargy and anorexia, respectively.

31 rising diffuse muscle and joint pain, fever, lethargy and anorexia.

32 ses in animals, including anorexia, adipsia, lethargy and changes in temperature, collectively termed

33 0.89, 95% CI=-1.74 to -0.04) and transformed lethargy and hyperactivity subscale scores (common inter

34 ossessed enhanced virulence, causing greater lethargy and mortality, with an extended tropism for bra

35 ayed, protracted vomiting and accompanied by lethargy and pallor, usually 1 to 4 hours after ingestin

36 ad treatment-related serious adverse events (lethargy and supraventricular extrasystoles).

37 ommonly reported adverse event was prolonged lethargy and unresponsiveness (17 of 21 [81%]) followed

38 ent caused poor tolerability (poor grooming, lethargy) and significantly higher day-14 RAD and cyclos

39 Fever, lethargy, and anorexia were the most common clinical sig

40 g postnatal development as well as alopecia, lethargy, and ataxia.

41 High fever, weight loss, anorexia, extreme lethargy, and diarrhea were observed.

42 severe disease include high temperature and lethargy, and lumbar puncture might reveal pleocytosis.

43 t of E. coli invasion, respiratory distress, lethargy, and mortality was dependent on the bacterial d

44 H7N8 HPAI virus caused moderate weight loss, lethargy, and mortality.

45 gies and include severe repetitive vomiting, lethargy, and pallor.

46 ic behavioral responses, including anorexia, lethargy, and social withdrawal.

47 apy; one cat had acute onset of anorexia and lethargy, and two cats had clinical signs that were not

48 disease episodes including fever, diarrhea, lethargy, anemia, and thrombocytopenia.

49 They typically have a history of lethargy, anorexia, and weight loss in the months preced

50 fferential diagnoses of dogs presenting with lethargy, anorexia, fever, and lameness, particularly in

51 l injection of high-dose drug, which elicits lethargy, anorexia, weight loss, and peritoneal fibrosis

52 t inactivation of CGRP(PBN) neurons prevents lethargy, anxiety and malaise associated with cancer.

53 nflammatory (IL-1B) and behavioral outcomes (lethargy, anxiety-like behavior).

54 opharyngeal, and skin symptoms, headache and lethargy, as well as to the occurrence of wheezing, coug

55 n is consistent with the clinical picture of lethargy, ataxia and cognitive deficits associated with

56 Lethargy, ataxia, or paralysis preceded death.

57 Anorexia, weight loss, muscle wasting, and lethargy became progressively severe, and all FIAU-treat

58 strongly or completely suppressed unc-43(gf) lethargy, but affected other mutants with reduced locomo

59 rthermore, the inhibitor completely prevents lethargy caused by bolus-injected nanoparticles, without

60 of FPIES are repetitive emesis, pallor, and lethargy; chronic FPIES can lead to failure to thrive.

61 most common symptoms in adults are fatigue, lethargy, cold intolerance, weight gain, constipation, c

62 eased weight loss, diarrhea, inappetence and lethargy compared to either injury pattern alone.

63 tenuated sickness behaviors (hypothermia and lethargy) compared to LPS-treated controls.

64 Loss of Klc function results in progressive lethargy, crawling defects, and paralysis followed by de

65 e clinical signs of disease in mice included lethargy, dehydration, polyuria, polydypsia, and death.

66 Adverse events (eg, lethargy, diarrhoea, rash, and nausea) improved during t

67 and synaptic transmission and suppressed the lethargy, egg-laying defect, and deficient neurotransmit

68 physical response (tachypnea, piloerection, lethargy, etc), or intra-abdominal bowel inflammation/ad

69 esented with similar nonspecific symptoms of lethargy, fatigue, and nausea.

70 The central nervous dysfunctions of lethargy, fever and anorexia are manifestations of sepsi

71 D(50)) of either H5N1 virus exhibited severe lethargy, fever, weight loss, transient lymphopenia, and

72 fever (>/=38.5 degrees C), rigors, malaise, lethargy, flank pain, hematuria, suprapubic discomfort,

73 an in the sodium bicarbonate group (moderate lethargy: group A, 38.7% [29 of 75] and group C, 30.1% [

74 families (one consanguineous) presented with lethargy, hyperlactatemia, and hyperammonemia of unexpla

75 -42a leads to anachronistic larval molts and lethargy in adults.

76 tacopan also alleviates nanoparticle-induced lethargy in rats and severe hypotension in dogs.

77 However, rabphilin mutants exhibit severe lethargy in the absence of mechanical stimulation.

78 Anger/Irritability, Mood Swings, Overwhelm, Lethargy, Increased Appetite, Joint and Muscle Pain, and

79 Lethargy is characteristic of malnourished populations,

80 male copulation, the duration of post-coital lethargy is coupled to cellular events involved in ejacu

81 omatic or have non-specific symptoms such as lethargy, itch, or loss of appetite.

82 nset of initial clinical signs of influenza (lethargy, lack of appetite) to reflect clinically releva

83 ions and reduced sensorimotor integration to lethargy-like behaviors and delayed emergence from propo

84 bouts of movement less frequently indicating lethargy-like behaviors.

85 g severe acute gastrointestinal symptoms and lethargy, mainly affecting infants and young children.

86 nes three grades: mild (altered respiration, lethargy), moderate (gastrointestinal signs, a single se

87 blood leak alarm activation (n=6), confusion/lethargy (n=5), corneal opacification (n=4), cardiac arr

88 neutropenia (ten [12%] patients), fatigue or lethargy (nine [11%] patients), and infection (eight [10

89 Affected red deer had lethargy, ocular signs, and nasal discharge and were eut

90 s were isolated by their ability to suppress lethargy of an unc-64 syntaxin mutant that restricts neu

91 cal pain and granuloma formation, fever, and lethargy of grade 1 or 2 were observed.

92 unterpart, and is likely correlated with the lethargy of grain interior dislocation activities, frequ

93 -1-depleted PC12 cells and the lethality and lethargy of unc-64 (C. elegans orthologue of syntaxin-1)

94 ad no clinical (e.g., weight loss, diarrhea, lethargy) or histologic evidence of classical acute or c

95 ith normal blood counts, but with headaches, lethargy, or abdominal pain, reported symptom resolution

96 r (somnolence, sleep inversion or insomnia), lethargy, parkinsonism, dyskinesias and neuropsychiatric

97 Exaggerated sickness behavior (lethargy, piloerection, ptosis) in the GR(dim)-LPS mice

98 ls preceding clinical disease in the form of lethargy, respiratory distress, and mortality.

99 Toxicity was characterized by scratching, lethargy, respiratory distress, collapse, and death with

100 nclude agitation, hallucinations, psychosis, lethargy, seizures, tachycardia, dysrhythmias, hypertens

101 Glutathionuric mice exhibited lethargy, severe growth failure, shortened life spans an

102 sonance imaging scans, moderate motor delay, lethargy, severe hypotonia, and modest lactic acidosis.

103 This immune challenge caused prolonged lethargy, sickness behavior, and microglial reactivity i

104 e rhebok developed inappetence, weight loss, lethargy, signs related to pulmonary or arthral dysfunct

105 havior Checklist subscales for irritability, lethargy/social withdrawal, and hyperactivity; the Behav

106 were decreased appetite, diarrhoea, fatigue, lethargy, somnolence, and decreased weight.

107 berrant Behavior Checklist Social Withdrawal/Lethargy subscale.

108 thromboembolic events (ten [7%] vs 11 [8%]), lethargy (ten [7%] vs nine [7%]), oral mucositis (three

109 ad significantly more severe neutropenia and lethargy than those in cohort 1.

110 and symptoms of PBC, which include pruritus, lethargy, the sicca syndrome, and osteoporosis, closely

111 cebo; eight in that assigned to exemestane), lethargy (three; 11; 11), and nausea or vomiting (five;

112 /drinking, vomiting everything, convulsions, lethargy, unconsciousness, or head nodding).

113 Lethargy was more common in diphenhydramine groups than

114 dominal pain, facial and jaw pain, anorexia, lethargy, weakness, and night sweats; imaging revealed g

115 symptoms of hypothyroidism include fatigue, lethargy, weight gain, and cold intolerance; however, th

116 In contrast, weight loss and severe lethargy were not noted in ferrets infected with 10(7) E

117 Fever and lethargy were the most common clinical signs.

118 ays postinfection, all nine cats experienced lethargy which persisted 5 to 18 days.

119 ts included unsteadiness with gabapentin and lethargy with memantine.